Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (12)

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection

    Journal of Medical Virology, Vol. 96, Núm. 5

  3. Monkeypox virus genomic accordion strategies

    Nature Communications, Vol. 15, Núm. 1

  4. T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

2023

  1. Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis

    Frontiers in Cellular and Infection Microbiology, Vol. 13

2021

  1. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers

    AIDS, Vol. 35, Núm. 3, pp. 393-398

2020

  1. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

    Journal of Molecular Medicine, Vol. 98, Núm. 8, pp. 1093-1105

2019

  1. CD4 recovery is associated with genetic variation in IFNγ and IL19 genes

    Antiviral Research, Vol. 170

2018

  1. CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART

    Scientific Reports, Vol. 7, Núm. 1

2009

  1. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201

2004

  1. Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load

    Clinical Infectious Diseases, Vol. 39, Núm. 7, pp. 1024-1029